Insider Transactions Reported by 8 Insiders of Kairos Pharma, LTD.

Symbol
KAPA on NYSE
Location
Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 03 Jan 2025

Kairos Pharma, LTD. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John S. Yu CEO and Chairman, Director, 10%+ Owner $6,101,344 08 Oct 2025
Neil Bhowmick Chief Scientific Officer $931,334 08 Oct 2025
Ramachandran Murali VP of Research and Development $329,481 08 Oct 2025
Doug Samuelson Chief Financial Officer $322,342 08 Oct 2025
Rahul Singhvi Director $54,124 08 Oct 2025
Hyun W. Bae Director $52,092 16 Sep 2025
Hansoo Michael Keyoung Director $31,992 16 Sep 2025
ROSEMARY MAZANET Director 16 Sep 2024

Recent Insider Transactions by Companies or Individuals for Kairos Pharma, LTD.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.